Sanofi lowers Lantus insulin costs by 78% in U.S. market
Sanofi, a French pharmaceutical major, announced it would slash the price of insulin, Lantus, by 78% for all U.S. patients with commercial insurance.
Drugs
Medical
Pharma
Drugs
Medical
Pharma
Glenmark gets FDA nod for trials in US on tumour, cancer patients
Glenmark Specialty SA, a subsidiary of India’s Glenmark Pharmaceuticals, has got investigational new drug clearance from the FDA to conduct clinical trials in.
Drugs
Pharma
Dr. Reddy divests dermatology brands to Eris for INR 2.7b
India's Dr. Reddy's Laboratories has divested "certain" non-core dermatology brands of the company to Eris Lifesciences for INR 2.7 billion.
Drugs
Pharma
Janssen’s human trials for dengue virus to advance to phase II
Janssen Pharmaceutical Companies, a wholly-owned subsidiary of Johnson & Johnson, announced its first-in-human clinical trial of a compound to treat dengue had entered.
Drugs
Medical
Pharma
FDA nod for Pfizer-Biotech vaccine booster for children
The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four.
Drugs
Pharma
Novo Nordisk follows Eli Lilly on insulin price cuts
Denmark's Novo Nordisk plans to effect a 75% cut in insulin prices in the U.S. market by January 1, 2024.
Drugs
Medical
Pharma
Sanofi acquires Provention Bio for $2.9 billion to boost its diabetes portfolio
Sanofi acquires Provention Bio, and its TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D).
Drugs
Health
Medical
Leukaemia drug effective in treating breast cancer metastatic relapse
A mice study showed promising results in treating secondary recurrence of breast cancer in lungs
Drugs
Medical
Pharma
Pfizer to buy Seagen for $43 billion to fortify cancer portfolio
Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.
Drugs
Medical
Pharma
Merck says trial hypertension drug enhances patients’ walk time
Merck announced its experimental trial on patients with pulmonary arterial hypertension had led to an extension in walking distance and reduced exacerbating the.